CD44 and breast cancer: The first solid tumour stem cells were identified in breast cancer, where it was demonstrated that a CD44+CD24- marker-bearing subpopulation could regenerate a tumour from as little as 100 cells, whereas tens of thousands of cells from the bulk population failed to do so [5].